Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. (PYXS) is a healthcare company (biotechnology) based in the United States. The share price is $1.44, up 2.13% on the day, which values the company at $172.24M. Price as of 18 Nov 2026, 09:21 UTC, from Yahoo Finance.

Key facts

Share price
$1.44+2.13% today
Market value
$172.24M
200-week average
$2.5042% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Pyxis Oncology, Inc. in more detail

PYXS trades at -1.7× next year's expected earnings, 15.6× sales. It sits 42% below its 200-week average of $2.50.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Pyxis Oncology, Inc. (PYXS): questions and answers

What is Pyxis Oncology, Inc.'s market cap?

Pyxis Oncology, Inc. is valued at $172.24M at a share price of $1.44.

Is PYXS above its 200-week moving average?

No. PYXS is 42.5% below its 200-week average of $2.50. Long-term investors watch that line because strong companies rarely trade below it for long.

Does PYXS pay a dividend?

Pyxis Oncology, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Pyxis Oncology, Inc. (PYXS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/PYXS

Underlying data: Yahoo Finance; company filings with the SEC.